Hemoglobin (Hgb) >= 9 g/dlXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dL =< 2 weeks prior to randomizationXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable); obtained within 14 days prior to study entryXx_NEWLINE_xXMust have hemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.Xx_NEWLINE_xXHgb ? 10 g/dLXx_NEWLINE_xXHemoglobin (HGB) > 8.0 gm/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dL (with or without transfusion support)Xx_NEWLINE_xXHemoglobin (Hgb) > 9.0 g/dL, must be obtained within 8 weeks prior to screening for protocol therapyXx_NEWLINE_xXELIGIBILITY CRITERIA FOR RANDOMIZATION (STEP 1): Hemoglobin (Hgb) > 9.0 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 gr/dLXx_NEWLINE_xXWithin 60 days prior to registration on study: Hemoglobin (Hgb) >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)Xx_NEWLINE_xXWithin 14 days prior to registration: Hemoglobin (Hgb) >= 8 g/dlXx_NEWLINE_xXHemoglobin (Hgb) > 9.0 g/dL obtained =< 21 days prior to registrationXx_NEWLINE_xXHemoglobin >= 8.0 g/dl, within 21 days prior to registration (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable), within 21 days prior to study entryXx_NEWLINE_xXHemoglobin (Hgb) >= 8.5Xx_NEWLINE_xXObtained within 14 days prior to treatment start: Hemoglobin (HGB) >= 9 g/dlXx_NEWLINE_xXHemoglobin (HGB) >= 8 g/dL, within 14 days of registrationXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dlXx_NEWLINE_xXHemoglobin (Hgb) ? 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL obtained within 14 days prior to registrationXx_NEWLINE_xXProcurement: Hemoglobin (Hgb) > 8.0 g/dl (transfusions allowed)Xx_NEWLINE_xXPatients with Hgb > 8.0 g/dl (transfusion allowed)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) < 9 g/dL without growth factor or transfusion supportXx_NEWLINE_xXHemoglobin (Hgb) ? 80 g/LXx_NEWLINE_xXHemoglobin (Hgb) < 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dL;Xx_NEWLINE_xXHgb-A1C ? 7.5%;Xx_NEWLINE_xXHemoglobin (Hgb) > 10 g/dL within 14 days of starting cycle 1 day 1 treatmentXx_NEWLINE_xXHgb < 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (HGB) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HGB) > 8.0 gm/dL (patients may be transfused to achieve this HGB level);Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXPROCUREMENT: Hemoglobin (Hgb) > 8.0 (transfusions allowed)Xx_NEWLINE_xXTREATMENT: Hgb > 8.0 g/dL (transfusions allowed)Xx_NEWLINE_xXHemoglobin (HgB) > 8.0Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXHemoglobin (Hgb) ? 8.0 g/dL, stable for ? 1 weekXx_NEWLINE_xXHgb > 8.0 (transfusion allowed)Xx_NEWLINE_xXINCLUSION - PROCUREMENT: Hemoglobin (Hgb) > 8.0 (can be transfused)Xx_NEWLINE_xXHemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable), obtained within 30 days prior to registrationXx_NEWLINE_xXHemoglobin (HgB) > 9 g/dL. Must not have required transfusion of red blood cells within 1 week of baseline Hgb assessment.Xx_NEWLINE_xXINCLUSION - INFUSION: Hemoglobin (Hgb) > 8.0 (may be a transfused value)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHgb-A1C =< 7.5%Xx_NEWLINE_xXPROCUREMENT INCLUSION: Hemoglobin (Hgb) > 8.0 (may be a transfused value)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (with/without transfusion)Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dL, at the screening visitXx_NEWLINE_xXHgb ? 9 g/dLXx_NEWLINE_xXGlycosylated hemoglobin (Hgb A1c) =< 6.5%Xx_NEWLINE_xXHemoglobin (Hgb) >= 10.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dL (can be transfused)Xx_NEWLINE_xXHemoglobin ?9 g/dL (transfused Hgb allowed)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dL (can be transfused)Xx_NEWLINE_xXHemoglobin (Hgb) <9 g/dLXx_NEWLINE_xXOBTAINED =< 7 DAYS PRIOR TO REGISTRATION: Hemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHgb > 8.0 (transfusion allowed)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dL.Xx_NEWLINE_xXGlycated hemoglobin (Hgb-A1C) level of =< 7.5%.Xx_NEWLINE_xXHemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0 (can be transfused)Xx_NEWLINE_xXINCLUSION - TREATMENT: Hemoglobin (Hgb) ? 9.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= g/dl is acceptable)Xx_NEWLINE_xXHemoglobin > =10 g/dl. The use of transfusion or other intervention to achieve Hgb ?10.0 g/dl is acceptable.Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXAnemia (hemoglobin [Hgb] < 10 g/dL)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL.Xx_NEWLINE_xXHemoglobin (Hgb) >= 8.5 g/dlXx_NEWLINE_xXHemoglobin (Hgb) < 8 mg/dl, per PI discretion if thought to be related to underlying myelomaXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9 g/dL compatible for surgeryXx_NEWLINE_xXObtained =< 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HgB) < 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (more than 48 hours post-completion of blood transfusion)Xx_NEWLINE_xXObtained within 28 days prior to registration: Hemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXWithin 28 days prior to registration: Hemoglobin (Hgb) >= 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (in absence of blood transfusion).Xx_NEWLINE_xXHemoglobin (Hgb) > 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) =< 10.0 orXx_NEWLINE_xXHemoglobin (Hgb) > 7.5 gm/dLXx_NEWLINE_xXObtained within 28 days prior to registration: hemoglobin (Hgb) >= 8.0 g/dl; Note: The use of transfusion or other intervention to achieve Hgb >= 8.0 g/dl is acceptableXx_NEWLINE_xXWithin 4 weeks of day 1: Hemoglobin (HgB) >= 10.0 gr/dL independent of transfusionXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL.Xx_NEWLINE_xXHemoglobin (Hgb) < 8 mg/dlXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/L without (w/o) transfusion within 7 days of assessment.Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL; (last transfusion cannot be within 7 days of trial initiation)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (within 16 days before starting therapy)Xx_NEWLINE_xXHgb >= 10 g/dL ((within 16 days before starting therapy)Xx_NEWLINE_xXHemoglobin (HGB) >= 10 g/dlXx_NEWLINE_xXHGB of > 10 g/LXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptableXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)Xx_NEWLINE_xXWithin 14 days prior to cycle 1 day 1 of treatment: Hemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dlXx_NEWLINE_xXHemoglobin (HGB) > 9.0 g/dL, within 30 days before study registrationXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXWithin 4 weeks prior to the registration: hemoglobin >= 8.0 g/dl (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HGB) >= 7 g/dl without transfusion or growth factor support for at least 1 weekXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dl within 30 days of enrollment to studyXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (obtained within 28 days prior to first study treatment)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.5 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 9.0 g/dL, within 14 days prior to treatmentXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL.Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL, within 14 days start of study startXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dLXx_NEWLINE_xXHemoglobin (HGB) < 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 gm/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 8 gr/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXEXCLUSION CRITERIA FOR PATIENTS WITH NSCLC OR TNBC (COHORT B): Hemoglobin (Hgb) < 9 mg/dl (transfusion permitted to achieve this)Xx_NEWLINE_xXObtained =< 14 days prior to registration: Hemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXPRIOR TO CELL PROCUREMENT: Hemoglobin (Hgb) ? 8.0 g/dL (transfusion independent for 2 weeks prior to enrollment)Xx_NEWLINE_xXHemoglobin (Hgb) > 8 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL without transfusionsXx_NEWLINE_xXHemoglobin (Hgb) ? 90 g/L (9 g/dL).Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXWithin 14 days prior to registration: Hemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHgb ?10 g/dL - can be transfusedXx_NEWLINE_xXWithin 3 months of registration: Hemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (transfusions allowed)Xx_NEWLINE_xXHgb ? 9 g/dLXx_NEWLINE_xXWithin 14 days prior to study entry: Hemoglobin (Hgb) > 9.0 g/dL (with or without transfusion)Xx_NEWLINE_xXWithin 6 weeks of day 1: Hemoglobin (HgB) >= 9.0 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) > 10 within 30 days of consentXx_NEWLINE_xXHemoglobin (Hgb) > 9 within 45 days of consentXx_NEWLINE_xXHemoglobin (Hgb) >= 10.0 gm/dl within 14 days of study entryXx_NEWLINE_xXHemoglobin (HgB) >= 9 g/dLXx_NEWLINE_xXAT THE TIME OF INFUSION: Hemoglobin (Hgb) ? 8.0Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXTREATMENT: Hemoglobin (Hgb) > 8.0 g/dLXx_NEWLINE_xXHemoglobin (HGB) >= 9 g/dl (please note: it is acceptable from the standpoint of study eligibility to undergo transfusion in order to achieve hemoglobin >= 9 g/dl)Xx_NEWLINE_xXHemoglobin (Hgb) <9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8Xx_NEWLINE_xXPROCUREMENT: Hemoglobin (Hgb) > 8.0 (transfusions allowed)Xx_NEWLINE_xXTREATMENT: Hgb > 8.0 (transfusion allowed)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 (may be transfused).Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dl, obtained =< 14 days prior to registrationXx_NEWLINE_xXHemoglobin (Hgb) greater than 10 g/LXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXWithin 30 days of first vaccination: Hemoglobin (Hgb) >= 10 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HgB) > 8.0Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL (obtained =< 7 days prior to registration)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9Xx_NEWLINE_xXHemoglobin >= 9.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXWithin 14 days prior to registration: Hemoglobin (Hgb) >= 9.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 9.0 is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHgb > 8.0Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dlXx_NEWLINE_xXHemoglobin >= 8 g/dl (Note: the use of transfusion to achieve hemoglobin [Hgb] >= 8 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8.5 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dlXx_NEWLINE_xXHemoglobin (HGB) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 (may be a transfused value)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)Xx_NEWLINE_xXAt least one laboratory abnormality probably or definitely attributed to KSHV-MCD\r\n* Anemia (hemoglobin [Hgb] [men] =< 12.5 gm/dL, Hgb [women] =< 11 gm/dL)\r\n* Thrombocytopenia (=< 130,000/mm^3)\r\n* Hypoalbuminemia (< 3.4 g/dL)Xx_NEWLINE_xXHemoglobin (Hgb) < 8 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] > 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (HgB) > 9.0 g/dL; NOTE: subjects may not have had a transfusion within 7 days of registrationXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXWithin 14 days prior to registration: Hemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9 g/dL for mono-therapyXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL without transfusionsXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) less than or equal to 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8 g/dLXx_NEWLINE_xXTo be performed within 28 days prior to day 1 of protocol therapy: Hemoglobin (Hgb) >= 8 g/dL without transfusionsXx_NEWLINE_xXHemoglobin >= 9.0 g/dl; (Note: The use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)Xx_NEWLINE_xXWithin 14 days prior to step 1 registration: Hemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin: >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dL, obtained within 14 days prior to registration for protocol therapyXx_NEWLINE_xXHemoglobin (HgB) > 9.0 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXObtained within 30 days prior to registration: Hemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) < 9 g/dLXx_NEWLINE_xXHemoglobin >= 9.0 g/dL (patients may be transfused to meet hemoglobin [Hgb] requirement)Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) > 10Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptable; within 14 days prior to registrationXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (NOTE: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 8.0 g/dL is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dl (transfusion acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 10.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 10.0 g/dL is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 9.0 g/dL is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL (transfusions allowed)Xx_NEWLINE_xXHemoglobin >= 10.0 g/dL (note: the use of transfusion or other intervention to achieve Hgb >= 10.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXAnemia (hemoglobin [Hgb] < 10 g/dL)Xx_NEWLINE_xXHGB ?10 g/dl and not transfusion dependentXx_NEWLINE_xXHemoglobin (Hgb) ? 90 g/L,Xx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8.0 g/dL (transfusion or other intervention to achieve Hgb >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHgb > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dlXx_NEWLINE_xXHemoglobin (HgB) > 9 g/dL (acceptable to reach this by transfusion)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dL.Xx_NEWLINE_xXHgb ?9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dlXx_NEWLINE_xXHemoglobin (HgB) >= 9Xx_NEWLINE_xXWithin 14 days of study start: Hemoglobin (Hgb) >= 9 g/dL (may transfuse if clinically indicated)Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dL (can be achieved with transfusion)Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXHemoglobin >= 8.0 g/dL (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8 gm/dL (transfusion independent)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (HgB) ?9 g/dL.Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL (no red blood cell [RBC] transfusion within past 14 days)\r\n* Hgb >= 8.0 g/dL for patients with anemia associated diseaseXx_NEWLINE_xXGlycosylated hemoglobin (Hgb A1C) > 8.0%Xx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dL (within 16 days before starting therapy)Xx_NEWLINE_xXHemoglobin (Hgb) > 9Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dlXx_NEWLINE_xXObtained within 14 weeks prior to registration on study: hemoglobin >= 8.0 g/dl (the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) > 9.0 g/dL obtained within 14 days prior to registrationXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (which may be post transfusion)Xx_NEWLINE_xXHemoglobin (Hgb) greater than or equal to 9 g/dLXx_NEWLINE_xXHemoglobin (HGB) >= 10 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 9.5 g/dL (transfusion before treatment is allowable if more than 3 days prior to study start)Xx_NEWLINE_xXHemoglobin (Hgb) > 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL (90 g/L) without blood transfusion within 7 daysXx_NEWLINE_xXHemoglobin >= 8.0 g/dL (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dL is acceptable)Xx_NEWLINE_xXHemoglobin (HgB) >= 10.0 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) greater than or equal to 9 g/dL (transfusions are allowed)Xx_NEWLINE_xXAT THE TIME OF INFUSION: Hemoglobin (Hgb) > 8.0g/dl (can be transfused)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXhemoglobin (Hgb) > 9.9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) A1C =< 8%Xx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl within 30 days prior to registration; Note: the use of transfusion or other intervention to achieve hemoglobin (Hgb) >= 8.0 g/dl is acceptableXx_NEWLINE_xXHemoglobin (HGB) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 9 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dL (within 16 days before starting therapy)Xx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 8.5 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >8.0gm/dLXx_NEWLINE_xXObtained within 2 weeks from study entry: Hemoglobin (HgB) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dlXx_NEWLINE_xXHemoglobin (Hgb) ? 10 g/dlXx_NEWLINE_xXHemoglobin (Hgb) ? 10 g/dl.Xx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) < 7.0Xx_NEWLINE_xXObtained =< 7 days prior to registration: Hemoglobin (Hgb) > 9.0 mg/dlXx_NEWLINE_xXHemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dlXx_NEWLINE_xXHemoglobin (hgb) =< 10.0 orXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 mg/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 gm/dL (unless due to bone marrow infiltration by tumor in which case Hgb > 8 gm/dL)Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dL (use of transfusion to reach this threshold prior to study initiation is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 mg/dL (which may be post transfusion)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL may be supported by transfusion and/or hematopoetic growth factorsXx_NEWLINE_xXHemoglobin (Hgb) >= 9g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL (transfusion allowed), within 14 days of registrationXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dlXx_NEWLINE_xXHemoglobin (HGB) >= 8 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin ? 8.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ?8.0 g/dl is acceptable).Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (NOTE: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL without transfusionsXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dL.Xx_NEWLINE_xXHemoglobin >= 9.0 g/dl; (note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) < 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ?10 g/dLXx_NEWLINE_xXHemoglobin (HgB) > 9.0 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dLXx_NEWLINE_xXSELUMETINIB ARM: Hemoglobin (Hgb) < 9.0 g/dLXx_NEWLINE_xXHemoglobin (HgB) >= 8.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/LXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHgB < 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HgB)>8.0 (may be transfused)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHGB >9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dL;Xx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dL.Xx_NEWLINE_xXHemoglobin (HgB) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dL within 14 days prior to randomization. Must not have required transfusion within 1 week of baseline Hgb assessment.Xx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL without transfusionsXx_NEWLINE_xXDoes the subject have a Hgb ? 10 g/dL?Xx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/LXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dL obtained =< 7 days prior to registrationXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dL.Xx_NEWLINE_xXHgb > 7.5 g/dl (without transfusion within 7 days)Xx_NEWLINE_xXHemoglobin (Hgb) ? 8.0 g/dL at Baseline (within 24 hours prior to surgical procedure).Xx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 8.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ? 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (HGB) >= 9 gm/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 10.0 gm/dL (Note: the use of transfusion or other intervention to achieve Hgb >= 10.0 is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (HgB) > 8.5 g/dLXx_NEWLINE_xXHemoglobin (Hgb) ?9.5 g/dlXx_NEWLINE_xXHemoglobin (Hgb) A1C =< 8%Xx_NEWLINE_xXHemoglobin (Hgb) A1C =< 8%Xx_NEWLINE_xXHemoglobin (HgB) > 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) > 9.0 gms/dlXx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dlXx_NEWLINE_xXHemoglobin (Hgb) >= 8 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL without transfusionsXx_NEWLINE_xXHemoglobin (Hgb) > 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin >= 9.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 9.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin ? 9.0 g/dl (Note: The use of transfusion or other intervention to achieve Hgb ? 9.0 g/dl is acceptable.)Xx_NEWLINE_xXEvidence of iron deficiency anemia including, hemoglobin (Hgb) < 11 g/dL, but > 8 g/dL; and transferrin saturation (TSAT) < 20%Xx_NEWLINE_xXSevere anemia with hemoglobin (HGB) < 10Xx_NEWLINE_xXSubjects who have diabetes with a hemoglobin (Hgb) A1c > 7Xx_NEWLINE_xXHemoglobin (Hgb) ? 9.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL or >= 5.6 mmol/LXx_NEWLINE_xXHemoglobin (HgB) >= 9.0 g/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (Note: the use of transfusion or other intervention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (Hgb) ?>= 8.0 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9.0Xx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXHemoglobin (Hgb) > 8.0 g/dLXx_NEWLINE_xXHgb ? 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 10 g/dl within 90 days of enrollmentXx_NEWLINE_xXHemoglobin (Hgb) >= 8.0g/dLXx_NEWLINE_xXHemoglobin (Hgb) within normal limits for institution/labXx_NEWLINE_xXHemoglobin (Hgb) ? 8 g/dL.Xx_NEWLINE_xXHemoglobin (Hgb) > 10.0 g/dL with no blood transfusion in the past 28 daysXx_NEWLINE_xXHemoglobin (Hgb) ? 10 g/dlXx_NEWLINE_xXHemoglobin (Hgb) > 8.0Xx_NEWLINE_xXHemoglobin (hgb) ? 8.0 g/dL (may be supported with transfusion)Xx_NEWLINE_xXObtained within 28 days prior to registration: Hemoglobin (Hgb) >= 9 g/dLXx_NEWLINE_xXHemoglobin (Hgb) >= 9 g/dL (90 g/L); < 9 g/dL (< 90 g/L) is acceptable if Hgb is corrected to >= 9 g/dL (90 g/L) as by growth factor or transfusion prior to PET scan, obtained within 14 days prior to PET scanXx_NEWLINE_xXHemoglobin (hgb) > 10 G/dLXx_NEWLINE_xXHemoglobin >= 8.0 g/dl (the use of transfusion or other invention to achieve hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin >= 8.0 g/dl (The use of transfusion or other invention to achieve Hemoglobin [Hgb] >= 8.0 g/dl is acceptable)Xx_NEWLINE_xXHemoglobin (HgB) > 9 mg/dLXx_NEWLINE_xX